XIGDUO XR | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

XIGDUO XR
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Metrochem Dapagliflozin

Contact Supplier

CHSD Dapagliflozin

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Dapagliflozin

Contact Supplier

XIGDUO XR

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 33 USDMF, 4 JDMF, 12 EU WC, 18 KDMF, 11 NDC API, 70 Listed Suppliers, $ API Reference Price

94 API Suppliers
33 USDMF
4 JDMF
12 EU WC
18 KDMF
11 NDC API
70 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

49 Drugs in Development

49 Drugs in Development

INTERMEDIATES

85 Intermediate Suppliers

85 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

218 FDF Dossiers, 32 FDA Orange Book, 57 Europe, 26 Canada, 6 Australia, 18 South Africa, 79 Listed Dossiers

218 FDF Dossiers
32 FDA Orange Book
57 Europe
26 Canada
6 Australia
18 South Africa
79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG

TABLET;ORAL - 10MG
TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 5 Corel Pharma Chem, 4 DFE Pharma, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 12 Kerry, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
2 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
1 Clariant
5 Corel Pharma Chem
4 DFE Pharma
7 Gangwal Chemicals
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
12 Kerry
8 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
2 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

26 Fillers, Diluents & Binders, 21 Coating Systems & Additives, 14 Disintegrants & Superdisintegrants, 12 Lubricants & Glidants, 11 Direct Compression, 11 Thickeners and Stabilizers, 8 Granulation, 8 Controlled & Modified Release, 6 Co-Processed Excipients, 5 Film Formers & Plasticizers, 3 Taste Masking, 3 Topical, 3 Rheology Modifiers, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Coloring Agents, 2 Chewable & Orodispersible Aids, 2 Parenteral, 1 Surfactant & Foaming Agents

26 Fillers, Diluents & Binders
21 Coating Systems & Additives
14 Disintegrants & Superdisintegrants
12 Lubricants & Glidants
11 Direct Compression
11 Thickeners and Stabilizers
8 Granulation
8 Controlled & Modified Release
6 Co-Processed Excipients
5 Film Formers & Plasticizers
3 Taste Masking
3 Topical
3 Rheology Modifiers
3 Emulsifying Agents
2 API Stability Enhancers
2 Coloring Agents
2 Chewable & Orodispersible Aids
2 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 211 News #PharmaBuzz

3 Data Compilation #PharmaFlow
211 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 57 Regulatory FDF Prices, 18 Annual Reports

2 US Medicaid Prescriptions
57 Regulatory FDF Prices
18 Annual Reports

MARKET PLACE

37 APIs, 12 FDF Dossiers

37 APIs
12 FDF Dossiers

PATENTS & EXCLUSIVITIES

195 US Patents, 18 US Exclusivities

195 US Patents
18 US Exclusivities

REF. STANDARDS & IMPURITIES

46 Others

46 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,969 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

18 All

01 18ASTRAZENECA AB

filter Product Reset all filters

18 All

01 8DAPAGLIFLOZIN

02 10DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

18 All

01 22026-05-08

02 22026-11-08

03 72027-06-12

04 72027-12-12

filter Exclusivity Code Reset all filters

18 All

01 2M-298

02 7NPP

03 9PED

Polpharma Dapagliflozin

Product Main Page

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

205649

Product Number

1

Exclusivity Details

01

ASTRAZENECA AB

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 205649

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

202293

Product Number

2

Exclusivity Details

02

ASTRAZENECA AB

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 202293

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-298

Exclusivity Expiration Date

2026-05-08

Application Number

202293

Product Number

2

Exclusivity Details

03

ASTRAZENECA AB

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN

Exclusivity Code : M-298

Exclusivity Expiration Date : 2026-05-08

Application Number : 202293

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

202293

Product Number

1

Exclusivity Details

04

ASTRAZENECA AB

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 202293

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2026-11-08

Application Number

202293

Product Number

1

Exclusivity Details

05

ASTRAZENECA AB

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN

Exclusivity Code : PED

Exclusivity Expiration Date : 2026-11-08

Application Number : 202293

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-298

Exclusivity Expiration Date

2026-05-08

Application Number

202293

Product Number

1

Exclusivity Details

06

ASTRAZENECA AB

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN

Exclusivity Code : M-298

Exclusivity Expiration Date : 2026-05-08

Application Number : 202293

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

205649

Product Number

5

Exclusivity Details

07

ASTRAZENECA AB

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 205649

Product Number : 5

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

205649

Product Number

4

Exclusivity Details

08

ASTRAZENECA AB

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 205649

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

205649

Product Number

3

Exclusivity Details

09

ASTRAZENECA AB

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 205649

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

ASTRAZENECA AB

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-06-12

Application Number

205649

Product Number

2

Exclusivity Details

10

ASTRAZENECA AB

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

ASCO Annual meeting

Not Confirmed

ASTRAZENECA AB

United Kingdom

ASCO Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-06-12

Application Number : 205649

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!